Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc reports results for the quarter ended in June - Earnings Summary

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of $1.32​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was
for earnings of one cent per share.
    * Revenue rose 20.1% to $17.54 million from a year ago;
analysts
expected $20.46 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of $1.32​.
    * The mean earnings estimate of analysts had risen by
about 101.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had risen by 7.2% this
quarter and
gained 15.5% so far this year.
    * The company reported a quarterly loss of $10.7 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:20 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.01           -1.32          Missed
 Mar. 31 2023      -0.51          -0.71          Missed
 Dec. 31 2022      -0.33          -0.54          Missed
 Sep. 30 2022      -0.40          -0.75          Missed

Recent news on Alimera Sciences

See all news